Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
DARE
$0.83
-1.19%
DARE
· Dare Bioscience, Inc.
$0.83
-0.01 (-1.19%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's current analysis of the conditions described above, there is substantial doubt about the Company's ability to continue as a going concern within the 12 month period from the issuance date of the accompanying condensed consolidated financial statements given that the timing and amount of potential revenue the Company may generate remain uncertain.”View the 10-Q filed Aug 13, 2026
Market Cap
$13.29M
Shares
15.29M
Volume · Oct 6
88.57K
Avg daily vol (3M)
518.77K
All webcasts
Earnings call · FY2024 Q4
Dare Bioscience, Inc. (DARE) Q4 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
-$63,647
-103.5% YoY
Net income · derived Q4
-$5.51M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 31, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 31, 2025 · complete as-filed document